Physician profile
Kevin E Sadowski
NPI 1205885340
$7,652.86
in general payments reported to CMS, 2019-2025
17 companies · $973 in 2025
The $973 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $560 · 2021: $1,933 · 2022: $1,757 · 2023: $1,281 · 2024: $1,149 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,403.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $2,507.48 | 2019-2025 | Ztlido |
| Abbvie INC. | $1,961.55 | 2021-2025 | |
| Pfizer INC. | $860.18 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $608.79 | 2021-2024 | Ajovy, Austedo |
| Biohaven Pharmaceutical Holding Company Ltd. | $396.66 | 2022 | |
| Amgen INC. | $331.81 | 2019-2023 | Aimovig |
| Biohaven Pharmaceuticals, INC. | $326.98 | 2021 | |
| Bioventus LLC | $164.63 | 2021-2023 | Durolane |
| Horizon Therapeutics Plc | $108.81 | 2021-2022 | |
| Fidia Pharma USA INC. | $102.95 | 2019-2024 | Hymovis |
| Ibsa Pharma INC. | $65.77 | 2023 | Tirosint, Licart |
| Pacira Therapeutics, INC. | $60.31 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $50.47 | 2022-2024 | Iovera, Zilretta |
| Allergan, INC. | $42.30 | 2021 | |
| Lilly USA, LLC | $30.20 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $21.53 | 2023 | Orthovisc, Monovisc |
| Currax Pharmaceuticals LLC | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Sadowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.